Aflibercept reduces subfoveal fluid in eyes with persistent exudative AMD

Aflibercept yielded positive anatomic results in cases of exudative age-related macular degeneration that were resistant to ranibizumab or bevacizumab, according to a study.“Visual acuity did not improve. Aflibercept may be beneficial anatomically in cases of exudative AMD treated with persistent fluid on ranibizumab and/or bevacizumab,” the study authors said.

BLOG: Gonioprism simplifies iStent implantation

About a year ago, my partners and I began using the iStent trabecular bypass device shortly after its approval by the U.S. Food and Drug Administration.This wonderful device has changed our thinking about cataract surgery and the glaucoma patient, allowing us to lower pressure in the vast majority of cases with a fairly simple device whose implantation accompanies cataract surgery nicely. I have used it in 25 to 30 patients, including two undergoing Descemet’s stripping endothelial keratoplasty surgery simultaneously with cataract extraction.

Targeted eye care education urged for adults with diabetes

The utilization of eye care among patients with diabetes requires education targeted at financial barriers and comprehension of ophthalmic implications of their disease, according to researchers.“In the United States, Medicare covers an annual eye examination for those with diabetes, and most health insurance covers medical eye examination and payment for eye diseases such as diabetic retinopathy, cataract, and glaucoma. However, 25% to 47% of those with diabetes do not have yearly eye examinations,” Chiu-Fang Chou, DrPH, of the division of diabetes translation at the National Center for Chronic Disease Prevention (Read more...)